We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+3.61%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$8.02B
AUM Growth
+$84.9M
(+1.1%)
Cap. Flow
-$19.9M
Cap. Flow
% of AUM
-0.25%
Top 10 Holdings %
Top 10 Hldgs %
22.36%
Holding
1,205
New
120
Increased
406
Reduced
545
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$14.3M |
| 2 |
CME Group
CME
|
+$11.7M |
| 3 |
AbbVie
ABBV
|
+$11.5M |
| 4 |
Medtronic
MDT
|
+$11.3M |
| 5 |
Las Vegas Sands
LVS
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HP
HPQ
|
+$23.7M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$22.3M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$15.7M |
| 4 |
CGI
GIB
|
+$15.3M |
| 5 |
Scotiabank
BNS
|
+$11.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.41% |
| 2 | Healthcare | 18.92% |
| 3 | Technology | 13.03% |
| 4 | Communication Services | 10.02% |
| 5 | Consumer Staples | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENTL
826
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $285K | ﹤0.01% |
+13,000
| New | +$281K |
|
827
Chord Energy
CHRD
$7.68B
| $284K | ﹤0.01% |
+20,000
| New | +$294K |
|
|
OSIR
828
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $283K | ﹤0.01% |
16,100
-2,300
| -13% | -$38.6K |
|
829
Portland General Electric
POR
$5.67B
| $281K | ﹤0.01% |
7,574
-582
| -7% | -$21.9K |
|
830
Geron
GERN
$949M
| $278K | ﹤0.01% |
73,700
-10,500
| -12% | -$35.6K |
|
831
Integra LifeSciences
IART
$1.34B
| $277K | ﹤0.01% |
+11,009
| New | +$260K |
|
|
NFX
832
DELISTED
Newfield Exploration
NFX
| $275K | ﹤0.01% |
+7,848
| New | +$238K |
|
|
DISCK
833
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $274K | ﹤0.01% |
9,225
-414
| -4% | -$12.5K |
|
834
Telefônica Brasil
VIV
$19.1B
| $271K | ﹤0.01% |
17,700
| – | – |
|
835
Enanta Pharmaceuticals
ENTA
$400M
| $269K | ﹤0.01% |
+8,800
| New | +$342K |
|
|
AMRI
836
DELISTED
Albany Molecular Research Inc
AMRI
| $269K | ﹤0.01% |
15,300
-2,100
| -12% | -$35.8K |
|
837
Alaska Air
ALK
$5.35B
| $268K | ﹤0.01% |
4,049
-51,911
| -93% | -$3.37M |
|
838
Federal Realty Investment Trust
FRT
$10.2B
| $268K | ﹤0.01% |
1,802
-188
| -9% | -$27K |
|
839
Cincinnati Financial
CINF
$26.7B
| $267K | ﹤0.01% |
4,997
+950
| +23% | +$49.7K |
|
|
FPRX
840
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $267K | ﹤0.01% |
+11,700
| New | +$295K |
|
841
Qorvo
QRVO
$8.59B
| $265K | ﹤0.01% |
+3,320
| New | +$236K |
|
|
PETX
842
DELISTED
Aratana Therapeutics, Inc.
PETX
| $264K | ﹤0.01% |
+16,300
| New | +$290K |
|
843
CNX Resources
CNX
$5.32B
| $262K | ﹤0.01% |
11,422
-1,084
| -9% | -$27.6K |
|
844
Realty Income
O
$58.3B
| $262K | ﹤0.01% |
5,245
-412
| -7% | -$20.6K |
|
845
Theravance Biopharma
TBPH
$875M
| $262K | ﹤0.01% |
+15,100
| New | +$277K |
|
|
CYBX
846
DELISTED
CYBERONICS INC
CYBX
| $260K | ﹤0.01% |
+4,000
| New | +$244K |
|
847
Domino's
DPZ
$11.4B
| $258K | ﹤0.01% |
+2,569
| New | +$258K |
|
|
XENT
848
DELISTED
Intersect ENT, Inc
XENT
| $258K | ﹤0.01% |
+10,000
| New | +$229K |
|
|
JKS
849
JinkoSolar
JKS
$887M
| $257K | ﹤0.01% |
+10,000
| New | +$212K |
|
850
Sarepta Therapeutics
SRPT
$1.78B
| $257K | ﹤0.01% |
19,383
-2,600
| -12% | -$34.7K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q1 2015 Portfolio in Review
As of Q1 2015, DekaBank Deutsche Girozentrale held 1,205 positions worth $8.02B, up 1.1% from $7.94B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
DekaBank Deutsche Girozentrale's Q1 2015 filing shows 120 new, 406 increased, 545 reduced and 56 closed positions. Its largest new stake was Walgreens Boots Alliance: 93,746 shares worth $8.03M. The largest sale was HP, an estimated $23.7M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Technology.
- DekaBank Deutsche Girozentrale's largest Q1 2015 buy was Walgreens Boots Alliance: 93,746 shares worth $8.03M.
- DekaBank Deutsche Girozentrale added most to Alphabet (Google) Class C in Q1 2015, an estimated $14.3M increase.
- DekaBank Deutsche Girozentrale's biggest Q1 2015 reduction was HP, cutting an estimated $23.7M.
- DekaBank Deutsche Girozentrale fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $22.3M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 22% of its $8.02B portfolio in Q1 2015.
- DekaBank Deutsche Girozentrale opened 120 new positions and closed 56 in Q1 2015.
- DekaBank Deutsche Girozentrale's portfolio value rose 1.1% quarter-over-quarter to $8.02B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2015, filed 5 May 2015.